Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Aichi, Japan.
Dig Endosc. 2022 Mar;34(3):632-640. doi: 10.1111/den.14181. Epub 2021 Nov 17.
With the development of newer devices and technical innovations, pancreaticobiliary endoscopy is expanding to assume more advanced therapeutic roles. As with other devices, slimmed-down "3-Fr microcatheters" are considered to be opening new windows toward entirely new therapeutic techniques for various purposes. Our practical experience with a total of 34 consecutive patients in whom 3-Fr microcatheters were applied during pancreaticobiliary endoscopic procedures clarified the potential roles of this instrument in pancreaticobiliary endoscopy. The major benefits of 3-Fr microcatheters involve their slimness and flexibility. Applications of 3-Fr microcatheters could be categorized into three groups according to the characteristics of usage: (1) utilization as a cannulation catheter for peroral digital cholangioscopy (n = 15); (2) selective advancement through deep flexures or severely stenotic ducts (n = 11); or (3) two-devices-in-one-channel technique (n = 8). The microcatheter worked successfully for cannulation of cholangioscopy in all but one case (14/15, 93.3%). For selective advancement, the microcatheter worked for troubleshooting in 9 of 11 cases (81.8%). With the two-devices-in-one-channel technique, the microcatheter proved satisfactory in all cases (8/8, 100%). In total, the microcatheter was successfully maneuvered in 31 of 34 cases (91.1%), following the failure of procedures using conventional endoscopic techniques. In terms of adverse events, cystic duct injury was only observed in two cases (5.8%), who recovered under conservative observation, because its slimness could minimize the damage. We believe that 3-Fr microcatheters offer effective and safe salvage troubleshooting during various endoscopic pancreaticobiliary procedures that face troublesome situations with conventional strategies.
随着新型设备和技术创新的发展,胰胆内镜技术正在扩展,以承担更先进的治疗角色。与其他设备一样,“3Fr 微导管”的瘦身版被认为为各种目的的全新治疗技术开辟了新的途径。我们在总共 34 例连续患者中应用 3Fr 微导管的实践经验,阐明了该器械在胰胆内镜中的潜在作用。3Fr 微导管的主要优势在于其纤细和灵活。根据使用特点,3Fr 微导管的应用可分为三组:(1)作为经口数字胆管镜检查的插管导管(n=15);(2)选择性通过深曲或严重狭窄的胆管(n=11);或(3)双管一通道技术(n=8)。除 1 例(14/15,93.3%)外,微导管均成功用于胆管镜检查的插管。对于选择性推进,微导管在 9 例中有 11 例(81.8%)用于故障排除。使用双管一通道技术,微导管在所有 8 例中均令人满意(8/8,100%)。总共有 31 例(91.1%)在常规内镜技术失败后,成功地通过微导管进行了操作。在不良事件方面,仅在 2 例(5.8%)中观察到胆囊管损伤,这两例患者在保守观察下恢复,因为其纤细的设计可以最小化损伤。我们认为,在面临常规策略棘手情况的各种内镜胰胆手术中,3Fr 微导管提供了有效的、安全的故障排除救援。